GEOVAX LABS INC (GOVX) Stock Fundamental Analysis

NASDAQ:GOVX • US3736787058

1.63 USD
+0.1 (+6.54%)
At close: Feb 23, 2026
1.63 USD
0 (0%)
After Hours: 2/23/2026, 7:33:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to GOVX. GOVX was compared to 521 industry peers in the Biotechnology industry. GOVX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GOVX shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • GOVX had negative earnings in the past year.
  • GOVX had a negative operating cash flow in the past year.
  • In the past 5 years GOVX always reported negative net income.
  • GOVX had a negative operating cash flow in each of the past 5 years.
GOVX Yearly Net Income VS EBIT VS OCF VS FCFGOVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

  • GOVX has a worse Return On Assets (-375.99%) than 92.90% of its industry peers.
  • The Return On Equity of GOVX (-515.76%) is worse than 75.82% of its industry peers.
Industry RankSector Rank
ROA -375.99%
ROE -515.76%
ROIC N/A
ROA(3y)-210.29%
ROA(5y)-163.35%
ROE(3y)-332.78%
ROE(5y)-290.99%
ROIC(3y)N/A
ROIC(5y)N/A
GOVX Yearly ROA, ROE, ROICGOVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for GOVX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GOVX Yearly Profit, Operating, Gross MarginsGOVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • GOVX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for GOVX has been increased compared to 1 year ago.
  • Compared to 5 years ago, GOVX has more shares outstanding
  • GOVX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GOVX Yearly Shares OutstandingGOVX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100K 200K 300K 400K
GOVX Yearly Total Debt VS Total AssetsGOVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • GOVX has an Altman-Z score of -40.77. This is a bad value and indicates that GOVX is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -40.77, GOVX is not doing good in the industry: 90.21% of the companies in the same industry are doing better.
  • There is no outstanding debt for GOVX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -40.77
ROIC/WACCN/A
WACC8.72%
GOVX Yearly LT Debt VS Equity VS FCFGOVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

  • GOVX has a Current Ratio of 3.57. This indicates that GOVX is financially healthy and has no problem in meeting its short term obligations.
  • GOVX has a Current ratio (3.57) which is comparable to the rest of the industry.
  • GOVX has a Quick Ratio of 3.57. This indicates that GOVX is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of GOVX (3.57) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.57
Quick Ratio 3.57
GOVX Yearly Current Assets VS Current LiabilitesGOVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • The earnings per share for GOVX have decreased strongly by -47.87% in the last year.
  • Looking at the last year, GOVX shows a quite strong growth in Revenue. The Revenue has grown by 8.52% in the last year.
  • Measured over the past years, GOVX shows a very strong growth in Revenue. The Revenue has been growing by 27.45% on average per year.
EPS 1Y (TTM)-47.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-751.65%
Revenue 1Y (TTM)8.52%
Revenue growth 3Y117.28%
Revenue growth 5Y27.45%
Sales Q2Q%-100%

3.2 Future

  • The Earnings Per Share is expected to grow by 143.99% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 271.95% on average over the next years. This is a very strong growth
EPS Next Y-500.4%
EPS Next 2Y-121.41%
EPS Next 3Y143.99%
EPS Next 5YN/A
Revenue Next Year-54.79%
Revenue Next 2Y-41.42%
Revenue Next 3Y271.95%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GOVX Yearly Revenue VS EstimatesGOVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025 2027 50M 100M 150M 200M 250M
GOVX Yearly EPS VS EstimatesGOVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -100 -200 -300 -400

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GOVX. In the last year negative earnings were reported.
  • Also next year GOVX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GOVX Price Earnings VS Forward Price EarningsGOVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GOVX Per share dataGOVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20

4.3 Compensation for Growth

  • GOVX's earnings are expected to grow with 143.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-121.41%
EPS Next 3Y143.99%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • GOVX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GEOVAX LABS INC

NASDAQ:GOVX (2/23/2026, 7:33:00 PM)

After market: 1.63 0 (0%)

1.63

+0.1 (+6.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-13
Earnings (Next)03-25
Inst Owners8.59%
Inst Owner Change41.33%
Ins Owners0.29%
Ins Owner Change5.43%
Market Cap2.82M
Revenue(TTM)3.35M
Net Income(TTM)-25.31M
Analysts82
Price Target237.15 (14449.08%)
Short Float %18.59%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5%
Min EPS beat(2)-14.69%
Max EPS beat(2)4.68%
EPS beat(4)3
Avg EPS beat(4)21.38%
Min EPS beat(4)-14.69%
Max EPS beat(4)61.7%
EPS beat(8)6
Avg EPS beat(8)-19.57%
EPS beat(12)8
Avg EPS beat(12)-15.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2248.48%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2318.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-2493.91%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.84
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.57
EV/EBITDA N/A
EPS(TTM)-28.05
EYN/A
EPS(NY)-27.79
Fwd EYN/A
FCF(TTM)-14.04
FCFYN/A
OCF(TTM)-14.03
OCFYN/A
SpS1.94
BVpS2.84
TBVpS2.84
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -375.99%
ROE -515.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-210.29%
ROA(5y)-163.35%
ROE(3y)-332.78%
ROE(5y)-290.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.23%
Cap/Sales 0.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.57
Quick Ratio 3.57
Altman-Z -40.77
F-Score4
WACC8.72%
ROIC/WACCN/A
Cap/Depr(3y)108.76%
Cap/Depr(5y)249.22%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-751.65%
EPS Next Y-500.4%
EPS Next 2Y-121.41%
EPS Next 3Y143.99%
EPS Next 5YN/A
Revenue 1Y (TTM)8.52%
Revenue growth 3Y117.28%
Revenue growth 5Y27.45%
Sales Q2Q%-100%
Revenue Next Year-54.79%
Revenue Next 2Y-41.42%
Revenue Next 3Y271.95%
Revenue Next 5YN/A
EBIT growth 1Y-4.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-83000.3%
EBIT Next 3Y649.13%
EBIT Next 5YN/A
FCF growth 1Y-10.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.5%
OCF growth 3YN/A
OCF growth 5YN/A

GEOVAX LABS INC / GOVX FAQ

What is the ChartMill fundamental rating of GEOVAX LABS INC (GOVX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to GOVX.


What is the valuation status for GOVX stock?

ChartMill assigns a valuation rating of 1 / 10 to GEOVAX LABS INC (GOVX). This can be considered as Overvalued.


How profitable is GEOVAX LABS INC (GOVX) stock?

GEOVAX LABS INC (GOVX) has a profitability rating of 0 / 10.


Can you provide the financial health for GOVX stock?

The financial health rating of GEOVAX LABS INC (GOVX) is 6 / 10.


What is the earnings growth outlook for GEOVAX LABS INC?

The Earnings per Share (EPS) of GEOVAX LABS INC (GOVX) is expected to decline by -500.4% in the next year.